Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 02 02 2024] - (CGWL)
-
Xtant Medical to Participate in Upcoming Investor Conferences
-
Form 8.3 - [SMART METERING PLC - 02 02 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 02 02 2024) - (CGWL)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 02 02 2024] - (CGWL)
-
Onkos Surgical to Present at Canaccord Genuity's 2024 Musculoskeletal Conference
-
Form 8.3 - [SMART METERING PLC - 01 02 2024] - (CGWL)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 01 02 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 01 02 2024) - (CGWL)
-
HIVE Digital Announces Filing of Final Prospectus and Automatic Exercise of Special Warrants
-
Railtown AI Technologies Inc. Engages Canaccord Genuity Corp. as Exclusive Financial Advisor
-
Form 8.3 - [WINCANTON PLC - 31 01 2024] - (CGAML)
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 31 01 2024] - (CGWL)
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
-
Revive Therapeutics Ltd. Announces Closing of the First Tranche of Its Private Placement for Gross Proceeds of $913,500
-
KEYIMPACT AND WAYPOINT COMBINE TO FORM BEST-IN-CLASS AWAY-FROM-HOME FOOD SOLUTIONS AGENCY, ACXION FOODSERVICE
-
Form 8.3 - [PROPERTY FRANCHISE GROUP PLC (THE) - 30 01 2024] - (CGAML)
-
Form 8.3 - [MOLTEN VENTURES PLC - 30 01 2024] - (CGAML)
-
Form 8.3 - [LXi REIT PLC - 30 01 2024) - (CGWL)
-
Form 8.3 - [KIN AND CARTA PLC - 30 01 2024] - (CGAML)
-
Form 8.3 - [BELVOIR GROUP PLC - 30 01 2024] - (CGAML)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 30 01 2024] - (CGWL)
-
Hyalex Orthopaedics to Present at Canaccord Genuity 2024 Musculoskeletal Conference
-
Canaccord Genuity Upgrades Stryker (SYK) to Buy, 'Making strides with a strong guide'
-
Form 8.3 - [MOLTEN VENTURES PLC - 29 01 2024] - (CGAML)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 29 01 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 29 01 2024) - (CGWL)
-
Exro Technologies (EXROF) to Merge with SEA Electric
-
Exro Announces Merger with SEA Electric to Create Leading e-Mobility Technology Company
-
ATEC to Present at Upcoming Conferences
-
GFT acquires Sophos Solutions from Advent International
-
Form 8.3 - [LXi REIT PLC - 26 01 2024) - (CGWL)
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 26 01 2024] - (CGWL)
-
Form 8.3 - (musicMagpie plc - 26 01 2024) - CGAML
-
Q4 & Full Year 2023 Production Results and Operating Highlights
-
Q4 & Full Year 2023 Production Results and Operating Highlights
-
Form 8.3 - [LONDONMETRIC PROPERTY PLC - 25 01 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 25 01 2024] - CGWL
-
Form 8.3 - [musicMagpie plc - 25 01 2024] - (CGAML)
-
Form 8.3 - [SMART METERING PLC - 25 01 2024] - (CGWL)
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 25 01 2024] - (CGWL)
-
Metals Acquisition Limited Progresses Australian Securities Exchange Dual Listing with Lodgement of Prospectus
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 24 01 2024] - (CGWL)
-
Form 8.3 - [SMART METERING PLC - 24 01 2024] - (CGWL)
